Our Products
Sibnayal® - 8 mEq and 24 mEq prolonged-release granules. Potassium citrate/potassium hydrogen carbonate.
Adverse event reporting: Reporting suspected adverse reactions after authorisation of the medicinal product is important. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Advicenne@vigipharm.fr. Information about this product, including adverse reactions, precautions, contraindications, and method of administration can be found in the full SmPC. For a copy of the SmPC or further information please contact Advicenne@vigipharm.fr
NP/CNM/2026/022 February 2026

